-
PurposeMouse NrasG12D was amplified and mutated by PCR from IMAGE clone 6475312 (Invitrogen) and cloned downstream from the IRES; subsequently Luciferase was cloned upstream of the IRES
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 60834 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backboneMSCV
-
Backbone manufacturerClonetech
-
Modifications to backboneAll retroviruses were constructed in the MSCV backbone (Clontech). MSCV-IRES-Luciferase was generated by replacing GFP in MSCV-IRES-GFP with an NcoI/SalI fragment from pGL3-Basic (Promega) after excision of the 3′polyA signal. Mouse NrasG12D was amplified and mutated by PCR from IMAGE clone 6475312 (Invitrogen) and cloned downstream from the IRES; subsequently Luciferase was cloned upstream of the IRES.
-
Vector typeRetroviral
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)Top10
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameNrasG12D
-
gRNA/shRNA sequenceNrasG12D
-
SpeciesM. musculus (mouse)
-
Entrez GeneNras (a.k.a. N-ras)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site Eco (unknown if destroyed)
- 3′ cloning site Xho (unknown if destroyed)
- 5′ sequencing primer MSCV (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
MSCV-Luciferase-IRES-NrasG12D was a gift from Scott Lowe (Addgene plasmid # 60834 ; http://n2t.net/addgene:60834 ; RRID:Addgene_60834) -
For your References section:
Mouse models of human AML accurately predict chemotherapy response. Zuber J, Radtke I, Pardee TS, Zhao Z, Rappaport AR, Luo W, McCurrach ME, Yang MM, Dolan ME, Kogan SC, Downing JR, Lowe SW. Genes Dev. 2009 Apr 1;23(7):877-89. doi: 10.1101/gad.1771409. 10.1101/gad.1771409 PubMed 19339691